Lataa...
Trends in anemia management in hemodialysis patients with cancer
BACKGROUND: Erythropoiesis-stimulating agents (ESAs), intravenous iron, and blood transfusion are used to treat anemia in both end-stage renal disease (ESRD) and cancer. However, anemia treatment patterns have not been described among ESRD patients undergoing hemodialysis with concurrent cancer, esp...
Tallennettuna:
| Julkaisussa: | Am J Nephrol |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4618160/ https://ncbi.nlm.nih.gov/pubmed/26439712 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000440771 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|